NO20002124L - Nye karboksylsyrederivater med amid-sidekjeder, deres fremstilling og anvendelse som endothelin-reseptorantagonister - Google Patents
Nye karboksylsyrederivater med amid-sidekjeder, deres fremstilling og anvendelse som endothelin-reseptorantagonisterInfo
- Publication number
- NO20002124L NO20002124L NO20002124A NO20002124A NO20002124L NO 20002124 L NO20002124 L NO 20002124L NO 20002124 A NO20002124 A NO 20002124A NO 20002124 A NO20002124 A NO 20002124A NO 20002124 L NO20002124 L NO 20002124L
- Authority
- NO
- Norway
- Prior art keywords
- carboxylic acid
- acid derivatives
- receptor antagonists
- preparation
- endothelin receptor
- Prior art date
Links
- 229940118365 Endothelin receptor antagonist Drugs 0.000 title abstract 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 title abstract 2
- 239000002308 endothelin receptor antagonist Substances 0.000 title abstract 2
- 150000001408 amides Chemical group 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19748238 | 1997-10-31 | ||
| DE19752904A DE19752904A1 (de) | 1997-10-31 | 1997-11-28 | Neue Carbonsäurederivate, die Amidseitenketten tragen, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten |
| DE1998109376 DE19809376A1 (de) | 1998-03-05 | 1998-03-05 | Neue Carbonsäurederivate, die Amidseitenketten tragen, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten |
| PCT/EP1998/006571 WO1999023078A2 (fr) | 1997-10-31 | 1998-10-16 | Nouveaux derives d'acide carboxylique, portant des chaines laterales amidees; leur mode de production et leur utilisation en tant qu'antagonistes recepteurs d'endotheline |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20002124D0 NO20002124D0 (no) | 2000-04-26 |
| NO20002124L true NO20002124L (no) | 2000-04-26 |
Family
ID=27217881
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20002124A NO20002124L (no) | 1997-10-31 | 2000-04-26 | Nye karboksylsyrederivater med amid-sidekjeder, deres fremstilling og anvendelse som endothelin-reseptorantagonister |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6509341B1 (fr) |
| EP (1) | EP1027338A2 (fr) |
| JP (1) | JP2001521927A (fr) |
| CN (1) | CN1278251A (fr) |
| AU (1) | AU2266199A (fr) |
| BG (1) | BG104396A (fr) |
| BR (1) | BR9814951A (fr) |
| CA (1) | CA2307770A1 (fr) |
| HR (1) | HRP980560A2 (fr) |
| HU (1) | HUP0100054A3 (fr) |
| ID (1) | ID24278A (fr) |
| IL (1) | IL135347A0 (fr) |
| NO (1) | NO20002124L (fr) |
| NZ (1) | NZ504316A (fr) |
| PL (1) | PL340871A1 (fr) |
| SK (1) | SK4592000A3 (fr) |
| TR (1) | TR200001182T2 (fr) |
| WO (1) | WO1999023078A2 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19806438A1 (de) * | 1998-02-17 | 1999-08-19 | Basf Ag | Neue Carbonsäurederivate mit 5-substituiertem Pyrimidinring, ihre Herstellung und Verwendung |
| DE19933164A1 (de) * | 1999-07-20 | 2001-01-25 | Basf Ag | Neue Carbonsäurederivate mit 5,6 substituiertem Pyrimidinring, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten |
| EP1288202A4 (fr) | 2000-05-11 | 2003-07-02 | Banyu Pharma Co Ltd | Derives n-acyltetrahydroisoquinoline |
| DE10025728A1 (de) * | 2000-05-25 | 2001-11-29 | Basf Ag | Neue Carbamate und Harnstoffe, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten |
| WO2002064573A1 (fr) * | 2001-02-14 | 2002-08-22 | Abbott Gmbh & Co. Kg | Nouveaux derives d'acide carboxylique contenant des triazines a substitution alkyle, leur production et leur utilisation en tant qu'antagonistes du recepteur d'endotheline |
| DK1243262T3 (da) | 2001-03-20 | 2006-10-02 | Sanol Arznei Schwarz Gmbh | Hidtil ukendt anvendelse af en peptidklasse af forbindelser til behandling af ikke-neuropatiske, inflammatoriske smerter |
| ES2185606T3 (es) | 2001-03-21 | 2003-05-01 | Sanol Arznei Schwarz Gmbh | Nuevo uso de una clase de compuestos peptidicos para tratamiento de la alodinia u otros tipos diferentes de dolor cronico o fantasma. |
| KR20070007931A (ko) | 2004-04-16 | 2007-01-16 | 쉬바르츠파르마에이지 | 만성 두통의 예방 및 치료를 위한 펩티드 화합물의 용도 |
| EP1604656A1 (fr) | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Utilisation nouvelle de peptides pour le traitement de la sclérose amytrophique latérale (ALS) |
| PL1781276T3 (pl) | 2004-08-27 | 2010-11-30 | Ucb Pharma Gmbh | Zastosowanie związków peptydowych do leczenia bólu związanego z rakiem kości, bólu indukowanego przez chemioterapię oraz nukleozydy |
| SG174050A1 (en) * | 2006-04-13 | 2011-09-29 | Actelion Pharmaceuticals Ltd | Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis |
| WO2007144195A2 (fr) | 2006-06-15 | 2007-12-21 | Schwarz Pharma Ag | Composition pharmaceutique ayant un effet anticonvulsivant synergique |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4313413A1 (de) * | 1993-04-23 | 1994-10-27 | Basf Ag | 3-(Het)aryloxy(thio)-Carbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung |
| DE4313412A1 (de) | 1993-04-23 | 1994-10-27 | Basf Ag | 3-(Het)aryl-Carbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung |
| DE4411225A1 (de) | 1994-03-31 | 1995-10-05 | Basf Ag | Verwendung von Carbonsäurederivaten als Arzneimittel |
| DE19533023B4 (de) * | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| DE19614534A1 (de) | 1996-04-12 | 1997-10-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
-
1998
- 1998-10-16 WO PCT/EP1998/006571 patent/WO1999023078A2/fr not_active Ceased
- 1998-10-16 CA CA002307770A patent/CA2307770A1/fr not_active Abandoned
- 1998-10-16 US US09/529,860 patent/US6509341B1/en not_active Expired - Fee Related
- 1998-10-16 BR BR9814951-2A patent/BR9814951A/pt not_active IP Right Cessation
- 1998-10-16 PL PL98340871A patent/PL340871A1/xx unknown
- 1998-10-16 NZ NZ504316A patent/NZ504316A/xx unknown
- 1998-10-16 JP JP2000518953A patent/JP2001521927A/ja active Pending
- 1998-10-16 CN CN98810875A patent/CN1278251A/zh active Pending
- 1998-10-16 EP EP98966230A patent/EP1027338A2/fr not_active Withdrawn
- 1998-10-16 SK SK459-2000A patent/SK4592000A3/sk unknown
- 1998-10-16 HU HU0100054A patent/HUP0100054A3/hu unknown
- 1998-10-16 TR TR2000/01182T patent/TR200001182T2/xx unknown
- 1998-10-16 IL IL13534798A patent/IL135347A0/xx unknown
- 1998-10-16 AU AU22661/99A patent/AU2266199A/en not_active Abandoned
- 1998-10-16 ID IDW20000816A patent/ID24278A/id unknown
- 1998-10-26 HR HR19809376.4A patent/HRP980560A2/hr not_active Application Discontinuation
-
2000
- 2000-04-26 NO NO20002124A patent/NO20002124L/no not_active Application Discontinuation
- 2000-05-02 BG BG104396A patent/BG104396A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2307770A1 (fr) | 1999-05-14 |
| IL135347A0 (en) | 2001-05-20 |
| US6509341B1 (en) | 2003-01-21 |
| TR200001182T2 (tr) | 2000-11-21 |
| JP2001521927A (ja) | 2001-11-13 |
| WO1999023078A2 (fr) | 1999-05-14 |
| SK4592000A3 (en) | 2000-12-11 |
| EP1027338A2 (fr) | 2000-08-16 |
| ID24278A (id) | 2000-07-13 |
| CN1278251A (zh) | 2000-12-27 |
| BG104396A (en) | 2001-02-28 |
| NZ504316A (en) | 2002-12-20 |
| BR9814951A (pt) | 2000-10-03 |
| HRP980560A2 (en) | 1999-08-31 |
| HUP0100054A1 (hu) | 2002-02-28 |
| AU2266199A (en) | 1999-05-24 |
| WO1999023078A3 (fr) | 1999-09-10 |
| NO20002124D0 (no) | 2000-04-26 |
| PL340871A1 (en) | 2001-03-12 |
| HUP0100054A3 (en) | 2002-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1107281T1 (el) | Παραγωγα τροπανιου υποκατεστημενα με ιδιδαζοπυριδινη με ενεργοτητα ανταγωνιστη ccr5 υποδοχεα για τη θεραπεια hiv και φλεγμονης | |
| AU2003226572A1 (en) | Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors | |
| NO20002124L (no) | Nye karboksylsyrederivater med amid-sidekjeder, deres fremstilling og anvendelse som endothelin-reseptorantagonister | |
| SE0202463D0 (sv) | Novel compounds | |
| NO20070532L (no) | Substituerte 2-alkyl-kinazolinonderivater som PARP-inhibitorer | |
| CY1117029T1 (el) | Συνεργιστικοι μυκητοκτονοι συνδυασμοι δραστικων ουσιων | |
| NO20025590D0 (no) | Fenylglycin-derivater | |
| DE60226469D1 (de) | Biphenylkarbonsäureamidderivate als p38 kinase-inhibitoren | |
| DE60230127D1 (de) | Inhibitoren von integrin alpha-v-beta-6 | |
| NO20054848L (no) | Substituerte p-diaminobenzenderivater | |
| NO990662L (no) | Trombin-inhibitorer | |
| NO20064415L (no) | Nye amido-substituerte hydroksy-6-fenylfenantridiner og deres anvendelse som PDE4-inhibitorer | |
| NO20021502L (no) | Kinazolinoner | |
| NO20071111L (no) | Kynurensyreamidderivater som NR2B-reseptorantagonister | |
| NO20012544L (no) | Substituerte benzo[de]isokinolin-1,3-dioner | |
| NO20060702L (no) | Aminokinolinderivater og deres anvendelse som adenosin A3 ligander | |
| NO20052520L (no) | Nye sulfamider | |
| SE9903290D0 (sv) | Novel compounds | |
| CA2292775A1 (fr) | Cyanoguanidines utiles comme inhibiteurs de la proliferaiton cellulaire | |
| TR199901416T2 (xx) | Heterosiklik karbonikasit t�revleri. | |
| NO20002408D0 (no) | 5-HT1F antagonister | |
| NO20002154L (no) | Nye heterocykliske substituerte alfa-hydroksykarboksylsyre- derivater | |
| NO20001077L (no) | Nye karboksylsyrederivater, deres fremstilling og anvendelse som blandete ETA/ETB-endothelin-reseptorantagonister | |
| TR199903159T2 (xx) | Yeni �-Amino ve �-Azido karbonik asit t�revleri. | |
| NO20054721L (no) | Substituerte anilinderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |